Related Experiment Video

Updated: Aug 25, 2026

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

[Experimental study on doxorubicin as an adjunct to glaucoma surgery]

J M Ren

    [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
    |November 1, 1989
    PubMed

    Insights

    Doxorubicin effectively inhibits rabbit subconjunctival fibroblast proliferation in vitro and in vivo models of scarring. This chemotherapy drug shows promise for preventing scar tissue formation after ocular injury.

    Area of Science:

    • Ophthalmology
    • Pharmacology
    • Fibrosis Research

    Context:

    • Subconjunctival scarring can impair vision and ocular function.
    • Current treatments for preventing scar tissue formation are limited.
    • Fibroblast proliferation is a key process in scar development.

    Purpose:

    • To evaluate the in vitro and in vivo efficacy of doxorubicin in inhibiting subconjunctival fibroblast proliferation.
    • To determine the anti-scarring potential of doxorubicin in a rabbit model.

    Summary:

    • Eleven drugs were screened for their inhibitory effects on rabbit subconjunctival fibroblasts in vitro.
    • Doxorubicin demonstrated significant inhibitory action with an ID50 of 0.007 mg/L.
    • In vivo studies using a silk thread-induced scarring model showed doxorubicin reduced fibroblast thickness significantly compared to controls.
    • Pharmacokinetic analysis indicated therapeutic concentrations in the aqueous humor without exceeding toxic levels in the vitreous.

    Impact:

    • Doxorubicin shows potential as a therapeutic agent for preventing ocular subconjunctival scarring.
    • This research may lead to novel treatments for managing post-surgical or injury-related fibrosis in the eye.
    • Understanding doxorubicin's anti-fibrotic mechanisms could inform future drug development for ocular conditions.

    More Related Videos

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

    Published on: February 15, 2022

    Intracameral Injection in Rats with Low Risk of Adverse Effects06:19

    Intracameral Injection in Rats with Low Risk of Adverse Effects

    Published on: May 31, 2024

    Related Concept Videos

    Glaucoma: Overview01:25

    Glaucoma: Overview

    Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
    Open Angle Glaucoma: Treatment01:27

    Open Angle Glaucoma: Treatment

    In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
    Drugs such as carbonic anhydrase inhibitors, α2- and...
    Angle Closure Glaucoma: Treatment01:28

    Angle Closure Glaucoma: Treatment

    Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...